Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review
Journal of the American Heart Association · 15.04.2025 · 14 (8)
DOI: 10.1161/jaha.124.036533 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 15.04.2025. Verfasst von Martha Grogan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases Mayo Clinic Rochester MN USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Electrocardiography, Echocardiography, Amyloidosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Nonspecific symptoms and other diagnostic challenges lead to underdiagnosis of cardiac amyloidosis (CA). Artificial intelligence (AI) could help address these challenges, but a summary of the performance of these tools is lacking. This narrative review of published literature describes the performance of AI tools that use data from ECGs and echocardiography to improve identification of CA and challenges that hinder adoption of these tools. Thirteen studies met inclusion criteria with sample sizes ranging from 50 to 2451 patients. Four studies used ECG data, 8 used echocardiography data, and 1 used both. The CA gold standard was typically defined as a CA diagnosis in an institutional or other database but the requirements for these diagnoses were heterogenous across studies, and many did not distinguish among CA subtypes. AI model development varied considerably, and only 4 studies included external validation. The ability of models to predict CA ranged from 0.71 to 1.00, sensitivity ranged from 16% to 100%, and specificity from 75% to 100%. Only 1 study reported model performance across strata of sex, age, race, and CA type. Persistent challenges to AI adoption include usability, cost, value added, electronic health record/information technology interoperability, patient‐related factors, regulation, and privacy and liability. Published studies on AI for improved identification of CA show favorable performance measures but numerous methodologic and other challenges must be addressed before these tools are more widely adopted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Diseases Mayo Clinic Rochester MN USA.
- Attralus San Francisco CA USA.
- Pfizer Inc. New York NY USA.
- Amyloidosis Research Consortium Newton MA USA.
- Stanford University School of Medicine Stanford CA USA.
- IBM Research Yorktown Heights NY USA.
ORCID-Profile: Martha Grogan, Francisco Lopez-Jimenez, Spencer Guthrie, Isabelle Lousada, Ronald Witteles, Ajay Royyuru, Michael Rosenzweig, Sarah Cairns-Smith, David Ouyang
Zitieren
APA
Grogan, M., Lopez-Jimenez, F., Guthrie, S., Kumar, N., Langevin, R., Lousada, I., Witteles, R., Royyuru, A., Rosenzweig, M., Cairns-Smith, S., & Ouyang, D. (2025). Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review. Journal of the American Heart Association, 14(8). https://doi.org/10.1161/jaha.124.036533
Vancouver
Grogan M, Lopez-Jimenez F, Guthrie S, Kumar N, Langevin R, Lousada I, et al. Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review. Journal of the American Heart Association. 2025;14(8). doi:10.1161/jaha.124.036533
BibTeX
@article{Grogan2025,
author = {Grogan, Martha and Lopez-Jimenez, Francisco and Guthrie, Spencer and Kumar, Nisith and Langevin, Reuben and Lousada, Isabelle and Witteles, Ronald and Royyuru, Ajay and Rosenzweig, Michael and Cairns-Smith, Sarah and Ouyang, David},
title = {Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {8},
doi = {10.1161/jaha.124.036533}
}
EUVIMED